Ishihara Sangyo Kaisha Ltd. (4028.TO) Japan Year Ended March 31 GROUP 2026 2025 Revenue Y154.90 bln Y145.20 bln Operating Profit Y19.08 bln Y10.48 bln Pretax Profit Y21.74 bln Y11.39 bln Net Profit ...
Janome Sewing Machine Co. Ltd. (6445.TO) Japan Year Ended March 31 GROUP 2026 2025 Revenue Y38.97 bln Y36.34 bln Operating Profit Y1.91 bln Y2.22 bln Pretax Profit Y2.10 bln Y2.26 bln Net Profit ...
New AI models like Mythos are capable of finding software vulnerabilities on their own, discovering and exploiting holes in security that developers aren't aware of, at a speed that humans cannot ...
Major Chinese automaker Chery Automobile Co. and leading Japanese automotive parts retailer Autobacs Seven Co., among others, have plans to begin jointly selling new Chinese-made electric vehicles in ...
Japan Year Ended March 31 GROUP 2026 2025 Revenue Y90.16 bln Y80.19 bln Pretax Profit Y19.83 bln Y13.95 bln Net Profit Y14.09 bln Y9.78 bln Per share Earnings Y167.32 Y114.79 Diluted Earnings Y166.61 ...
South Korea's Kospi fell 1.9%, and Singapore's FTSE Straits Times Index edged 0.3% lower, while Japan's Nikkei Stock Average rose 0.5% and Hong Kong's Hang Seng Index added 0.3%. Write to Ronnie Harui ...
The biotech company has a pre-clinical program with the U.S. Army and a vaccine center at a Korean university.
The U.S. investment bank said Monday that current high global diesel margins are signaling scarcity risks, even if the OECD commercial diesel inventory coverage was 27 days of demand, exceeding the 25 ...
Strategy has sold more common stock to buy bitcoin, and Executive Chair Michael Saylor has posted a video on X in which he ...
Trump told CBS News in a phone interview that a suspension is “a great idea,” adding that his administration is “going to ...
West Pharmaceutical said after initially detecting an intrusion on May 4, it promptly activated its incident response protocols, including proactively taking systems offline globally for containment ...
MacroGenics agreed to sell its drug substance manufacturing operations to Bora Pharmaceuticals for $122.5 million upfront. MacroGenics, an antibody-based biopharmaceutical company, said Monday that ...